Ownership history in XTX Topco Ltd · 7 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ADAPTIMMUNE THERAPEUTICS PLC (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 353,836 | +251,335 | +245.2% | 0.00% | $9K | — |
| 2025 Q3 | ADDED | 102,501 | +22,479 | +28.1% | 0.00% | $13K | — |
| 2025 Q2 | ADDED | 80,022 | +67,623 | +545.4% | 0.00% | $19K | — |
| 2024 Q2 | REDUCED | 12,399 | -3,553 | -22.3% | 0.00% | $12K | — |
As of 2025 Q4 — sorted by position size